Efficacy of DOTS strategy in treatment of respiratory tuberculosis in Gorgan, Islamic Republic of Iran
AbstractWe carried out a follow-up cohort study of 260 smear-positive patients [178 on directly observed treatment, short-course [DOTS]; 82 on non-DOTS] over a 2-year period to evaluate the efficacy of the DOTS strategy in treatment of tuberculosis [TB]. All the patients had cough for > 3 weeks; 91.9% had fever, 60.8% of them with sputum; and 27.7% had a positive family history. The rate of treatment failure with DOTS was 9.0% at the end of the 2nd month and 1.7% at the beginning of the 5th month. In the control group these rates were 18.3% and 7.3% respectively. The DOTS strategy significantly increased the success rate of TB treatment [P < 0.05]
Abassi, A. & Mansourian, A.R. (2007). Efficacy of DOTS strategy in treatment of respiratory tuberculosis in Gorgan, Islamic Republic of Iran. EMHJ - Eastern Mediterranean Health Journal, 13 (3), 664-669, 2007 http://www.who.int/iris/handle/10665/117297
JournalEMHJ - Eastern Mediterranean Health Journal, 13 (3), 664-669, 2007
MetadataShow full item record
Showing items related by title and MeSH subject.
Using the Xpert MTB/RIF assay to detect pulmonary and extrapulmonary tuberculosis and rifampicin resistance in adults and children : expert group meeting report : 2013 World Health Organization (WHO/HTM/TB/2013.14, 2013)
Technique automatisée d’amplification de l’acide nucléique en temps réel pour la détection rapide et simultanée de la tuberculose et de la résistance à la rifampicine : système Xpert MTB/RIF : déclaration de principe Organisation mondiale de la Santé (WHO/HTM/TB/2011.4, 2011)